发明名称 Somatic stem cells
摘要 A method of treating a cellular proliferative disorder in a subject by obtaining from a subject a bodily fluid sample containing a plurality of cells, incubating the sample with EDTA or heparin in a container until the sample is separated into an upper layer and a lower layer, collecting the upper layer, isolating from the upper layer a population of somatic stem cells that are 0.3-6.0 micrometers in size, differentiating the somatic stem cells to dendritic cells in a medium containing GCSF, SCF, EGF, PDGF, bFGF, and IL-3, purifying the dendritic cells, contacting the dendritic cells thus purified with a cancer antigen, and administrating an effective amount of the dendritic cells presenting the cancer antigen to a subject in need thereof.
申请公布号 US8986679(B2) 申请公布日期 2015.03.24
申请号 US201313895686 申请日期 2013.05.16
申请人 Stembios Technologies, Inc. 发明人 Wang James
分类号 A61K39/00;C12N5/071;C12N5/074;A61K35/28;C12N5/0784;G01N33/50;A61K35/14;A61K35/12 主分类号 A61K39/00
代理机构 Cesari and McKenna, LLP 代理人 Cesari and McKenna, LLP
主权项 1. A method of treating a cellular proliferative disorder in a subject, the method comprising: obtaining a bodily fluid sample containing a plurality of cells, incubating the sample with EDTA or heparin in a container until the sample is separated into an upper layer and a lower layer, collecting the upper layer, isolating from the upper layer a population of somatic stem cells that are 0.3-6.0 micrometers in size and CD9+, differentiating the somatic stem cells to dendritic cells in a medium containing GCSF, SCF, EGF, PDGF, bFGF, and IL-3, the dendritic cells being CD83+ and CD86+, purifying the dendritic cells, contacting the dendritic cells thus purified with a cancer antigen, and administering an effective amount of the dendritic cells presenting the cancer antigen to a subject in need thereof.
地址 Monterey Park CA US
您可能感兴趣的专利